# Dataset 1
- **First author:** Lestat R. Ali  
- **Corresponding author(s):** Stephanie K. Dougan  
- **DOI:** [10.1158/1078-0432.CCR-23-1444](https://doi.org/10.1158/1078-0432.CCR-23-1444)  
- **Cancer type:** Pancreatic Ductal Adenocarcinoma (PDAC)  
- **Treatments:** Anti-PD-1 + Chemoradiation (CRT), CRT only  
- **Unique patients:** 3  
- **Sample types:** Blood, Tumor  
- **Timepoints:** Pre-Infusion, Post-Infusion 
- The dataset includes **gene expression**, **TCR**, and **metadata** files.

# Dataset 2
- **First author:** Ayse Bassez  
- **Corresponding author(s):** Diether Lambrechts, Ann Smeets 
- **DOI:** [https://doi.org/10.1038/s41591-021-01323-8](https://doi.org/10.1038/s41591-021-01323-8)
- Cancer type: Hormone receptor-positive or triple-negative breast cancer (TNBC)
- Treatments: Anti-PD-1 (Pembrolizumab) Â± Neoadjuvant chemotherapy
- Unique patients: 42
- Sample types: Tumor
- Timepoints: Pre-Infusion, Post-Infusion
- The dataset includes gene expression, TCR, and metadata files.



